开创心血管疾病细胞治疗的未来
Forging the Fate of Cellular Therapies for Cardiovascular Disease.
机构信息
From the Department of Internal Medicine, University of Kansas School of Medicine, Kansas University Medical Center, Kansas City, KS.
出版信息
Circ Res. 2017 Jun 9;120(12):1871-1873. doi: 10.1161/CIRCRESAHA.117.310970.
Abstract
The field of cell therapy for cardiovascular disease has progressed at an uneven rate and will likely follow the translational paths of other biologic therapies. The field will require novel public-private partnerships to guide it to its ultimate applications.
摘要
细胞治疗心血管疾病领域的进展参差不齐，可能会遵循其他生物疗法的转化途径。该领域需要新型的公私合作伙伴关系来指导其最终应用。
相似文献
1
Forging the Fate of Cellular Therapies for Cardiovascular Disease.开创心血管疾病细胞治疗的未来
Circ Res. 2017 Jun 9;120(12):1871-1873. doi: 10.1161/CIRCRESAHA.117.310970.
2
[Safety cell therapeutics/cell based medicinal products (CBMP)].[安全细胞疗法/基于细胞的医药产品（CBMP）]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1199-200. doi: 10.1007/s00103-015-2254-y.
3
Induced pluripotent stem cells for the study of cardiovascular disease.诱导多能干细胞在心血管疾病研究中的应用。
J Am Coll Cardiol. 2014 Aug 5;64(5):512-9. doi: 10.1016/j.jacc.2014.05.038.
4
Regulation Policy for Cell and Tissue Therapies in Australia.澳大利亚细胞与组织疗法监管政策
Tissue Eng Part A. 2015 Dec;21(23-24):2797-801. doi: 10.1089/ten.TEA.2014.0576. Epub 2015 Jul 22.
5
Natural Therapies for Cardiovascular Diseases.心血管疾病的自然疗法
Biomed Res Int. 2016;2016:4624378. doi: 10.1155/2016/4624378. Epub 2016 Dec 21.
6
Teeth-derived stem cells: A source for cell therapy.牙齿来源的干细胞：细胞治疗的一种来源。
J Cell Physiol. 2019 Mar;234(3):2426-2435. doi: 10.1002/jcp.27270. Epub 2018 Sep 21.
7
MicroRNA Therapeutics for Cardiac Regeneration.用于心脏再生的微小RNA疗法
Mini Rev Med Chem. 2015;15(6):441-51. doi: 10.2174/1389557515666150324123913.
8
Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders. Part 1: Conventional Therapy.社论：心血管疾病的传统、常规及替代疗法。第1部分：常规疗法。
Curr Pharm Des. 2017;23(6):859-860. doi: 10.2174/1381612823999170202114424.
9
Concise review: cell therapy and tissue engineering for cardiovascular disease.简明综述：细胞疗法和组织工程学治疗心血管疾病。
Stem Cells Transl Med. 2012 Feb;1(2):136-41. doi: 10.5966/sctm.2012-0030. Epub 2012 Jan 26.
10
Regenerative therapies for improving myocardial perfusion in patients with cardiovascular disease: failure to meet expectations but optimism for the future.用于改善心血管疾病患者心肌灌注的再生疗法：未能达到预期但对未来充满乐观。
Curr Vasc Pharmacol. 2012 May;10(3):300-9. doi: 10.2174/157016112799959396.
本文引用的文献
1
Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.源自诱导多能干细胞衍生物的外泌体：人类心脏病干细胞治疗的新方向。
Circ Res. 2017 Jan 20;120(2):407-417. doi: 10.1161/CIRCRESAHA.116.309307.
2
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.用于慢性缺血性心脏病和充血性心力衰竭的干细胞疗法。
Cochrane Database Syst Rev. 2016 Dec 24;12(12):CD007888. doi: 10.1002/14651858.CD007888.pub3.
3
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.RENEW 试验：心肌内自体 CD34(+)细胞给药治疗难治性心绞痛的疗效和安全性。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1576-85. doi: 10.1016/j.jcin.2016.05.003.
4
New and emerging targeted therapies for cystic fibrosis.囊性纤维化的新型及新兴靶向疗法。
BMJ. 2016 Mar 30;352:i859. doi: 10.1136/bmj.i859.
5
Long-term effect of gene therapy on Leber's congenital amaurosis.基因治疗对莱伯先天性黑蒙的长期影响。
N Engl J Med. 2015 May 14;372(20):1887-97. doi: 10.1056/NEJMoa1414221. Epub 2015 May 4.
6
Digoxin-specific antibody fragments in the treatment of digoxin toxicity.地高辛特异性抗体片段治疗地高辛中毒
Clin Toxicol (Phila). 2014 Sep-Oct;52(8):824-36. doi: 10.3109/15563650.2014.943907. Epub 2014 Aug 4.
7
Effect of nesiritide in patients with acute decompensated heart failure.奈西立肽治疗失代偿性心力衰竭的疗效。
N Engl J Med. 2011 Jul 7;365(1):32-43. doi: 10.1056/NEJMoa1100171.
8
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).开发一个网络来测试心血管细胞递药策略：美国国立卫生研究院赞助的心血管细胞治疗研究网络（CCTRN）。
J Cardiovasc Transl Res. 2010 Feb;3(1):30-6. doi: 10.1007/s12265-009-9160-3.
9
Paracrine mechanisms in adult stem cell signaling and therapy.成体干细胞信号传导与治疗中的旁分泌机制。
Circ Res. 2008 Nov 21;103(11):1204-19. doi: 10.1161/CIRCRESAHA.108.176826.
10
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.造血干细胞在缺血性心肌中分化为成熟的造血细胞。
Nature. 2004 Apr 8;428(6983):668-73. doi: 10.1038/nature02460. Epub 2004 Mar 21.
Zotero 插件